![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Fakih, Marwan G.; Kopetz, Scott; Kuboki, Yasutoshi; Kim, Tae Won; Munster, Pamela N.; Krauss, John C.; Falchook, Gerald S.; Han, Sae-Won; Heinemann, Volker; Muro, Kei; Strickler, John H.; Hong, David S.; Denlinger, Crystal S.; Girotto, Gustavo; Lee, Myung-Ah; Henary, Haby; Tran, Qui; Park, Joseph K.; Ngarmchamnanrith, Gataree; Prenen, Hans und Price, Timothy J.
(2022):
Sotorasib for previously treated colorectal cancers with KRAS(G12C) mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
In: Lancet Oncology, Bd. 23, Nr. 1: S. 115-124
Goey, Kaitlyn K. H.; Sorbye, Halfdan; Glimelius, Bengt; Adams, Richard A.; Andre, Thierry; Arnold, Dirk; Berlin, Jordan D.; Bodoky, Gyorgy; de Gramont, Aimery; Diaz-Rubio, Eduardo; Eng, Cathy; Falcone, Alfredo; Grothey, Axel; Heineman, Volker; Hochster, Howard S.; Kaplan, Richard S.; Kopetz, Scott; Labianca, Roberto; Lieu, Christopher H.; Meropol, Neal J.; Price, Timothy J.; Schilsky, Richard L.; Schmoll, Hans-Joachim; Shacham-Shmueli, Einat; Shi, Qian; Sobrero, Alberto F.; Souglakos, John; Cutsem, Eric van; Zalcberg, John; Oijen, Martijn G. H. van; Punt, Cornelis J. A. und Koopman, Miriam
(2018):
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
In: European Journal of Cancer, Bd. 100: S. 35-45